Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Changing the trajectory of chronic metabolic disease: the evolving role of GLP-1-based care

Meeting description
Add to Calendar
Download agenda
Thursday, 01 October 2026
18:45 - 18:50
(CEST)

Welcome and introduction

Alice Cheng
18:50 - 19:10
(CEST)

More than weight loss: focusing on outcomes that matter to people with obesity

Kirsi Pietiläinen
19:10 - 19:15
(CEST)

Patient case 1

Kirsi Pietiläinen
19:15 - 19:30
(CEST)

More than steatosis: Integrating liver health into metabolic disease management

Eric Lawitz
19:30 - 19:35
(CEST)

Patient case 2

Eric Lawitz
19:35 - 19:47
(CEST)

More than glycaemia: integrating metabolic and kidney risk management in T2D

Katherine Tuttle
19:47 - 19:55
(CEST)

Patient case 3

Katherine Tuttle
19:55 - 20:10
(CEST)

From risk factor control to long‑term health: what does ‘living longer and healthier’ mean in practice?

Alice Cheng, Kirsi Pietiläinen, Katherine Tuttle, Eric Lawitz
20:10 - 20:15
(CEST)

Key take‑home messages: acting early, treating holistically, personalising care

Alice Cheng
Keywords
Obesity
Congress industry session
GLP-1 RA
Semaglutide
PHASE 3 (RCT)